In this episode of Investor Connect, Hall T. Martin engages in a compelling conversation with Courtland Imel, a regulatory executive consultant and founder of Ceutical Labs. With over 24 years of experience in FDA compliance, Courtland shares his journey of aiding companies in remaining compliant and the industry's shift towards individualized medicine in the pharmaceutical and biotech sectors.

The discussion also touches on the implications of innovations in medical devices, the use of AI in development, and the regulatory challenges faced by AI-based medical devices. Courtland emphasizes the importance of having a narrow scope for AI-specific devices to gain regulatory approval and highlights the significant strides Ceutical Labs is making with 25 new products under development. He also shares investment insights, strategically focusing on the right talent, partnerships, and financial backing that are essential for scaling biotech startups. Lastly, the episode delves into the shifting landscapes of biotech hubs, the benefits of operating in Texas, and the future growth opportunities for Ceutical Labs.

Visit Ceutical Labs at ceuticallabs.com/

Reach out to at cimel@ceuticallabs.com, and on /www.linkedin.com/company/ceutical-laboratories-inc-/

_______________________________________________________

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org

Check out our other podcasts here: https://investorconnect.org/
For Investors check out: https://tencapital.group/investor-landing/
For Startups check out: https://tencapital.group/company-landing/
For eGuides check out: https:/_/tencapital.group/education/
For upcoming Events, check out https://tencapital.group/events/

For Feedback please contact info@tencapital.group

Please follow, share, and leave a review.

Music courtesy of Bensound.